To access this element change to forms mode OFF
Grant Award View - GA214894
Development of a novel topical serine protease inhibitor for tissue...
GA ID:
GA214894
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
21-Nov-2021
Publish Date:
24-Jan-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Jan-2025
Value (AUD):
$596,757.48
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Development of a novel topical serine protease inhibitor for tissue repair and inflammatory skin disease
Purpose:
Slow tissue repair, excessive scarring and many skin diseases are driven by the body’s inappropriate or excessive immune response to the injury or environmental trigger. A key enzyme that causes this excessive response is Granzyme B. We will develop a new drug that can target Granzyme B. We will generate the data to support the first in human trials of the drug at the end of this study to support translation to better treat patients with scarring, fibrosis and inflammatory skin disease.
GO ID:
GO Title:
NHMRC Development Grants 2021 for funding in 2022
Internal Reference ID:
2021/GNT2014416
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Western Australia
Recipient ABN:
37 882 817 280
Grant Recipient Location
Suburb:
Nedlands
Town/City:
Nedlands
Postcode:
6009
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, WA
Postcode:
Multiple
Country:
AUSTRALIA